** Shares of medical device maker Inogen rise 10.6% to $9.49 premarket
** Co says its device for clearing mucus from lungs has received FDA 510(k) approval
** FDA 510(k) approval is a process where a medical device is shown to be safe and similar to an existing device before it can be sold
** The device, SIMEOX 200 Airway Clearance Device, helps improve bronchial drainage in patients with chronic respiratory diseases - INGN
** The device is intended for patients who can cough on their own - INGN
** Co plans a limited launch of the device at targeted sites in 2025
** As of last close, stock has risen 56.3% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。